TNF and colorectal carcinoma: In crude comparative analyses of CRC, GLM use was associated with a higher HR versus use of other anti‐TNFα and TP therapies; however, the CIs were wide and included unity, and comparisons were based on sparse events (GLM, 2; other anti‐TNFα agents, 2; TPs, 3).